Outcome following intrastriatal fetal mesencephalic grafts for Parkinson's patients is directly related to the volume of grafted tissue

Experimental Neurology

Volumn 146, Issue 2, 1997, Pages 536-545

  Kopyov, Oleg V ^a   Jacques, Deane Skip ^a   Lieberman, Abraham ^b   Duma, Christopher M ^a   Rogers, Robert L ^a  

^a GOOD SAMARITAN HOSPITAL   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN GRAFT; BRAIN TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FETUS CELL; HUMAN; MALE; MESENCEPHALON; MOTOR PERFORMANCE; PARKINSON DISEASE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SURGICAL TECHNIQUE;

EID: 0031214299     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6577     Document Type: Article

References (34)

1. 1. Abrous, D. N., E. M. Torres, and S. B. Dunnett. 1993. Dopaminergic grafts implanted into the neonatal or adult striatum: Comparative effects on rotation and paw reaching deficits induced subsequent unilateral nigrostriatal lesions in adulthood. Neuroscience 54: 657-668.
2. 2. Annett, L. E. 1994. Functional studies of neural grafts in parkinsonian primates. In Functional Neural Transplantation (S. B. Dunnett and A. Bjorklund, Eds.), pp. 71-102. Raven Press, New York.
3. 3. Bjorklund, A., S. B. Dunnett, and G. Nikkhah. 1994. Nigral transplants in the rat Parkinson model. In Functional Neural Transplantation (S. B. Dunnett and A. Bjorklund, Eds.), pp. 47-69. Raven Press, New York.
4. 4. Bjorklund, A., and U. Stenevi. 1979. Reconstruction of the nigrostriatal pathway by intracerebral nigral transplants. Brain Res. 177: 555-560.
5. 5. CAPIT Committee. 1992. Core Assessment Program for Intracerebral Transplantations (CAPIT). Movement Disorders 7: 2-13.
6. 6. Cotzias, G. C., M. H. Van Woert, and L. M. Schiffer. 1967. Aromatic amino acids and modification of Parkinsonism. N. Engl J. Med. 276: 374-379.
7. 7. Doucet, G., Y. Murata, P. Brundin, O. Bosler, N. Mons, M. Geffard, C. C. Ouimet, and A. Bjorklund. 1989. Host afferents into intrastriatal transplants of fetal ventral mesencephalon. Exp. Neurol. 106: 1-19.
8. 8. Dunnett, S. B., A. Bjorklund, U. Stenevi, and S. D. Iversen. 1981. Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. I. Unilateral lesions. Brain Res. 215: 147-161.
9. 9. Dunnett, S. B., A. Bjorklund, U. Stenevi, and S. D. Iversen. 1981. Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. II. Bilateral lesions. Brain Res. 229: 457-470.
10. 10. Dunnett, S. B., and A. Bjorklund. 1994. Mechanisms of function of neural grafts in the injured brain. In Functional Neural Transplantation (S. B. Dunnett and A. Bjorklund, Eds.), pp. 531-567. Raven Press, New York.
11. 11. Freed, W. J., M. J. Perlow, F. Karoum, A. Seiger, L. Olson, B. J. Hoffer, and R. J. Wyatt. 1980. Restoration of dopaminergic function by grafting of fetal rat substantia nigra to the caudate nucleus: Long-term behavioral, biochemical, and histochemical studies. Ann. Neurol. 8: 510-519.
12. 12. Freed, C. R., R. E. Breeze, N. L. Rosenberg, S. A. Schneck, E. Kriek, J. X. Qi, T. Lone, Y. B. Zhang, J. A. Snyder, T. H. Wells, L. O. Ramig, L. Thompson, J. C. Mazziota, S. C. Huans, S. T. Grafton, D. Brooks, G. Sawle, G. Schroter, and A. A. Ansari. 1992. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N. Engl. J. Med. 327: 1549-1555.
13. 13. Freeman, T. B., C. W. Olanow, R. A. Hauser, G. M. Nauert, D. A. Smith, C. V. Borlongan, P. R. Sanberg, D. A. Holt, J. H. Kordower, F. Vingerhoets, B. J. Snow, D. Calne, and L. L. Gauger. 1995. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann. Neurol. 38: 379-388.
14. 14. Gash, D., M. Bresjanac, F. Junn, and Z. Zhang. 1994. Trophic mechanisms mediating functional recovery following intrastriatal implantation. In Functional Neural Transplantation (S. B. Dunnett and A. Bjorklund, Eds.), pp. 139-156. Raven Press, New York.
15. 15. Henderson, B. T. H., C. G. Clough, R. C. Hughes, E. R. Hitchcock, and B. G. Kenny. 1991. Implantation of human fetal ventral mesencephalon to the right caudate nucleus in advanced Parkinson's disease. Arch. Neurol. 48: 822-827.
16. 16. Jeanty, D., and R. Romero. 1984. Obstetrical Sonography. McGraw-Hill, New York.
17. 17. Kartzinel, R., I. Shoulson, and D. B. Calne. 1976. Studies with bromocriptine: Double-blind comparison with levodopa in idopathic parkinsonism. Neurology 26: 511-513.
18. 18. Kordower, J. H., T. B. Freeman, B. J. Snow, F. Vingerhoets, E. J. Mufson, P. R. Sanberg, R. A. Hauser, D. A. Smith, G. M. Nauert, D. P. Perl, and C. W. Olanow. 1995. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl J. Med. 332:1118-1124.
19. 19. Leenders, K. L., E. P. Salmon, P. Tyrrell, D. Perani, D. J. Brooks, H. Sager, T. Jones, C. D. Marsden, and S. J. Frackowiak. 1990. The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's Disease. Arch. Neurol. 47: 1290-1298.
20. 20. Lindvall, O. 1994. Neural transplantation in Parkinson's disease. In Functional Neural Transplantation (S. B. Dunnett and A. Bjorklund, Eds.), pp. 103-137. Raven Press, New York.
21. 21. Lindvall, O., P. Brundin, H. Widner, S. Rehncrona, B. Gustavii, R. Frackowiak, K. L. Leenders, G. Sawle, J. C. Rothwell, C. D. Marsden, and A. Bjorklund. 1990. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247: 574-577.
22. 22. Mahalik, T. J., T. E. Finger, I. Stromberg, and L. Olson. 1985. Substantia nigra transplants into denervated striatum of the rat: ultrastructure of graft and host interconnections. J. Comp. Neurol. 240: 60-70.
23. 23. Mandel, R., P. Brundin, and A. Bjorklund. 1990. The importance of graft placement and task complexity for transplant-induced recovery of simple and complex sensorimotor deficits in dopamine denervated rats. Eur. J. Neurosci. 2: 888-894.
24. 24. Molina, H., R. Quinones, L. Alvarez, et al. 1991. Transplantation of human fetal mesencephalic tissue in caudate nucleus as treatment for Parkinson's disease: The Cuban experience. In Intracerebral Transplantation in Movement Disorders: Experimental Basis and Clinical Experiences (O. Lindvall, A. Bjorklund, and H. Widner, Eds.), pp. 99-110. Elsevier, Amsterdam.
25. 25. Olanow, C. W., J. H. Kordower, and T. B. Freeman. 1996. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 19:102-109.
26. 26. Peschanski, M., G. Defer, J. P. N'Guyen, F. Ricolfi, J. C. Monfort, P. Remy, C. Geny, Y. Samson, P. Hantraye, and R. Jeny, et al. 1994. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 117: 487-499.
27. 27. Rioux, L., D. P. Gaudin, L. K. Bui, L. Gregoire, T. DiPaolo, and P. J. Bedard. 1991. Correlation of functional recovery after a 6-hydroxydopamine lesion with survival of grafted fetal neurons and release of dopamine in the striatum of the rat. Neuroscience 40: 123-131.
28. 14C]2-deoxy-D-glucose autoradiography. J. Neurochem. 38: 737-748.
29. 29. Spencer, D. D., R. J. Robbins, F. Naftolin, K. L. Marek, T. Vollmer, C. Leranth, R. H. Roth, L. H. Price, A. Gjedde, B. S. Bunney, K. J. Sass, J. D. Elsworth, E. L. Kier, R. Makuch, P. B. Hoffer, and D. E. Redmond. 1992. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N. Engl. J. Med. 327: 1541-1548.
30. 30. Strecker, R. E., T. Sharp, P. Brundin, T. Zetterstrom, U. Ungerstedt, and A. Bjorklund. 1987. Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intracerebral dialysis. Neuroscience 22: 169-178.
31. 31. Widner, H., J. Tetrud, S. Rehncrona, B. Snow, P. Brundin, B. Gustavii, A. Bjorklund, O. Lindvall, and J. W. Langston. 1992. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N. Engl J. Med. 327: 1556-1563.
32. 32. Wuerthele, S. M., W. J. Freed, L. Olson, J. Morihisa, L. Spoor, R. J. Wyatt, and B. J. Hoffer. 1981. Effect of dopamine agonists and antagonists on the electrical activity of substantia nigra neurons transplanted into the lateral ventricle of the rat. Exp. Brain Res. 44: 1-10.
33. 33. van Horne, C. G., T. Mahalik, B. Hoffer, M. Bygdeman, P. Almqvist, P. Stieg, A. Seiger, L. Olson, and I. Stromberg. 1990. Behavioral and electrophysiological correlates of human mesencephalic dopaminergic xenograft function in the rat striatum. Brain Res. Bull. 25: 325-334.
34. 34. Zetterstrom, T., P. Brundin, F. H. Gage, T. Sharp, O. Isacson, S. B. Dunnett, U. Ungerstedt, and A. Bjorklund. 1986. In vivo measurement of spontaneous release and metabolism of dopamine from intrastriatal nigral grafts using intracerebral dialysis. Brain Res. 362: 344-350.